Tatchempharmpreparaty, JSC
Quick facts
Phase 3 pipeline
- Dimephosphon® · Bone metabolism / Rheumatology
Dimephosphon is a bisphosphonate that inhibits bone resorption by suppressing osteoclast activity and promoting osteoclast apoptosis.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: